It was initially reported that a patient "infused himself" with a medication that was being delivered through patient controlled analgesia (pca) pump.The event allegedly resulted in an overdose.The customer believes that the patient "stole a key" to open the device.Bd has learned additional information through customer follow-ups.It was reported by the nurse manager of the manager medical/surgical/oncology unit that the patient "self-administered" 43 mg of dilaudid between (b)(6) "via pca pump bolus." on (b)(6) 2024, the issue was discovered when discrepancy in the doses was found.The pump was then exchanged, and patient "requested discharge in morning of (b)(6) 2024." per customer, "patient was safely discharged.".
|
Per 803.52(f)(11)(iii) the information provided represents all of the known information at this time.The complainant or reporter was unable or unwilling to provide any further patient, product, or procedural details to the manufacturer.H3 other text : device was not returned to manufacturing facility.
|